SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

$4CHAN is a meme token on the Ethereum Network.   4ChanToken represents a global crypto community that pays homage to the memetic powerhouses of the internet as Pepe, Doge, Shib and all major memes inventor combining them all into one super meme token that is $4CHAN. At its core, 4ChanToken embodies the untamed spirit of the notorious 4chan imageboard, where iconic memes are born, nurtured, and unleashed upon the world. With an unyielding spirit of irreverence and a touch of mischief, $4CHAN has emerged as the darling of meme enthusiasts, internet dwellers, and crypto aficionados alike.   The foundation of 4ChanToken lies in its community. We’ve harnessed the chaotic energy of this digital realm to create a currency that celebrates the power of memetic expression, empowering users to engage in a truly unique and decentralized economy. As a passionate supporter, you’ll join a vibrant ecosystem where dank memes and viral sensations are the lifeblood of commerce. 4ChanToken is more than just a digital currency – it’s the place where memes are born.  The ultimate playground for memelords and crypto degens. Based on the simplicity of holdrs/volume operating a store of value.  The identification of this value is best described as 'digital gold'. That $4chan can ultimately represent a superior store of value relative to all other forms of memecoins by embodying all memes in one token as the factual birthplace of all popular memes.

4Chan

$4CHAN is trending as community members rally around its potential as the 'Bitcoin of memecoins,' emphasizing its origin story and unique community. Discussions highlight the token's 13 zeros, creating an opportunity for significant gains, and its strong liquidity during market downturns. Some users express excitement about potential runs and whale accumulation, while others debate its long-term viability.

Monad is a high-performance Layer 1 blockchain that processes 10,000 transactions per second with near-zero fees. The platform delivers high performance without compromising on security or decentralization, creating the infrastructure needed for complex applications that require high-frequency activity.  One of Monad’s key innovations lies in how it handles transaction processing. Instead of processing transactions one at a time like traditional blockchains, Monad processes multiple transactions simultaneously through parallel execution.   The system separates the agreement process from the execution process, allowing validators to first agree on which transactions to include and in what order, then having more time to execute those transactions without slowing down consensus. This approach, combined with a custom-built database called MonadDB, dramatically increases throughput while maintaining accuracy.  Monad also offers complete EVM compatibility, where applications built for Ethereum work on Monad without any code modifications, and users can connect with familiar wallets like MetaMask just as they would on Ethereum. Developers can immediately tap into Ethereum's established ecosystem of tools, libraries, and applications while benefitting from Monad’s performance improvements. The platform also runs on consumer-grade hardware rather than expensive specialized equipment, making it accessible for more people to participate in securing the network.  Monad has raised approximately 244 million dollars in total funding across multiple rounds. The company secured 19 million dollars in a seed round in February 2023 led by Dragonfly Capital, followed by a 225 million dollar Series A round in April 2024 led by Paradigm at a 3 billion dollar valuation. Other notable investors include Electric Capital, Greenoaks, Coinbase Ventures, and prominent angel investors such as Naval Ravikant.

Monad

Monad (MON) is trending as the community discusses its potential as a high-speed, EVM-compatible blockchain, with some comparing it to early Ethereum and Solana. The community is focused on its Coinbase listing and potential for staking rewards, while also debating its market cap and long-term viability. Discussions also include speculation around future exchange listings and potential partnerships.

SPDR Gold Trust - SPDR Gold Shares ETF

SPDR Gold Shares ETF

GLD is trending as community members discuss potential catalysts, including speculation around upcoming economic data and central bank policy. Bullish sentiment suggests gold's safe-haven appeal is being recognized amid market uncertainty. Discussions also focus on technical analysis, with some eyeing breakout levels and others highlighting overbought conditions.

Memecoin on Cronos launched by the Cro Crow community

crow with knife

$CAW (crow with knife) is trending as the community rallies around its multichain functionality and deflationary tokenomics. Some believe $CAW could bring much-needed volume to the Cronos chain, while others are drawn to the active community and meme-driven appeal. The conversation includes discussion of bridging across chains like SOL, BASE, and BSC.

Based Chad

Based Chad is trending as community members highlight its relative strength compared to other memecoins amid market dips, emphasizing its diamond-handed community and unique buyback mechanisms. Discussions also suggest a potential connection to Coinbase, with executives reportedly holding the token and the meme gaining traction on the platform. The community anticipates further growth, pointing to upcoming video game integrations and staking opportunities.

Elevance Health, Inc. operates as a health company, which engages in improving lives and communities, and making healthcare simpler. It operates through the following segments: Health Benefits, CarelonRx, Carelon Services, and Corporate and Other. The Health Benefits segment offers a comprehensive suite of health plans and services to different customers. The CarelonRx segment markets and offers pharmacy services to affiliated health plan customers, as well as to external customers. The Carelon Services segment integrates physical, behavioral, pharmacy, and social services with the aim of delivering whole health affordably by offering a broad array of healthcare related services. The Corporate & Other segment includes businesses that do not individually meet the quantitative threshold for an operating segment. The company was founded in 1944 and is headquartered in Indianapolis, IN.

Elevance Health Inc

Elevance Health ($ELV) is trending as traders discuss options activity and potential upside, while analysts update ratings. Community members are weighing in on the company's valuation and its position relative to competitors within the managed care sector amid political and economic uncertainty impacting the broader healthcare landscape.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

SMMT is trending as traders discuss the potential for a short squeeze, pointing to high short interest and recent insider buying as key factors. Bullish sentiment is fueled by confidence in the company's pipeline and upcoming data releases, while bears express concerns about the impact of trial results on FDA approval and market competition. Community members are actively debating the company's valuation and potential catalysts.

Valneva SE is a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases addressing unmet medical needs. It currently provides three proprietary travel vaccines: IXIARO, DUKORAL, and IXCHIQ. The IXIARO is an inactivated Vero cell culture-derived Japanese encephalitis vaccine indicated for active immunization against Japanese encephalitis in adults, adolescents, children, and infants aged two months and older. The DUKORAL is a drinkable vaccine that helps prevent diarrhea caused by heat-labile toxin-producing ETEC, as well as cholera. The IXCHIQ is a single-dose, live-attenuated vaccine for the prevention of disease caused by chikungunya virus. The company also offers additional vaccines, including VLA1553, VLA15, VLA160, VLA200, VLA1601 and others. Valneva was founded on May 28, 2013 and is headquartered in Saint-Herblain, France.

Valneva SE - ADR

Valneva is trending due to positive Phase 2 booster results for its Lyme disease vaccine, developed in partnership with Pfizer, fueling speculation about a potential buyout. The community is focused on the significant revenue potential of the Lyme vaccine and anticipating Phase 3 trial data. Some investors express caution, referencing past setbacks, while others see the current low trading volume as an opportunity for exponential gains upon positive news.

SSgA Active Trust - Technology Select Sector SPDR ETF

Technology Select Sector SPDR Fund

XLK is trending due to a mix of factors including options activity and discussion around AI's impact on various tech companies and sectors. Community members are analyzing technical indicators and potential breakouts, while also weighing in on news related to specific companies like Apple, Nvidia, and Microsoft. The ETF's performance is being evaluated in the context of broader market trends and sector rotations.

WhiteFiber, Inc. provides AI and HPC infrastructure & cloud and data center solutions. It operates through the following segments: Cloud Services and Colocation Services. The Cloud Services segment offers computing services to support generative AI workstreams. The Colocation Services segment provides customers with physical space, power and cooling within the data center facility. The company was founded on August 15, 2024 and is headquartered in New York, NY.

Whitefiber Inc.

WhiteFiber, Inc.

WhiteFiber ($WYFI) is trending as traders discuss its potential in the AI data center market, particularly its retrofitting model and a possible upcoming contract announcement. Community members are actively monitoring the stock's price movement and potential for significant gains, with some pointing to institutional ownership and a low float as factors that could drive volatility. Chatter also revolves around how $WYFI relates to parent company $BTBT.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Bluebird Bio (BLUE) Reports Q1 Loss, Lags Revenue Estimates

Bluebird Bio, Inc. (BLUE) said on Wednesday that global investment firms Carlyle (CG) and SK Capital Partners have agreed to purchase all its outstanding shares and take the company private for $5 per share upfront.Under the terms of the <a target="_blank" rel="noopener noreferrer nofollow" href="https://investor.bluebirdbio.com/news-releases/news-release-details/carlyle-sk-capital-partners-and-bluebird-bio-amend-merger">amended</a> agreement, Bluebird stockholders can elect to receive either $3 per share in cash plus a contingent value right (CVR) of $6.84 per share in cash payable upon achievement of a net sales milestone or $5 per share in cash.The upfront payment of $5 represents a 51% premium to Bluebird’s closing price of $3.31 on Tuesday.Shares of the company traded over 50% higher on Wednesday morning.Gene therapy maker Bluebird first entered a definitive agreement with Carlyle and SK Capital in February. As per the original agreement, stockholders had only one option of receiving $3.00 per share in cash plus a CVR of $6.84 per share.Bluebird said the amended agreement allows an alternative for stockholders who would prefer greater upfront cash consideration instead of the potential upside of the CVR.The Bluebird board of directors recommended that shareholders tender their shares in support of the transaction by 11:59 p.m., New York City time, on May 29, 2025, following which the tender offer would expire.The company said that unless a majority of stockholders tender their shares, Bluebird is at significant risk of defaulting on its loan agreements with Hercules Capital, and it is extremely unlikely that stockholders would receive any consideration for their shares in a bankruptcy or liquidation.On Stocktwits, retail sentiment around Bluebird rose within the ‘bullish’ territory while message volume jumped from ‘high’ to ‘extremely high’ levels.<figure class="image"><img style="aspect-ratio:633/60;" src="https://news.stocktwits-cdn.com/Screenshot_2025_05_14_at_10_22_02_AM_png_1451c7b7eb.webp" alt="BLUE's Sentiment Meter and Message Volume as of 10:20 a.m. ET on May 14, 2025 | Source: Stocktwits" width="633" height="60"><figcaption>BLUE's Sentiment Meter and Message Volume as of 10:20 a.m. ET on May 14, 2025 | Source: Stocktwits</figcaption></figure> <a href="https://stocktwits.com/symbol/BLUE">BLUE stock</a> is down by about 43% this year and about 77% over the past 12 months.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/dynatrace-technology-q4-2025-earnings/chiqru4RbNS">Dynatrace Stock Rises On Upbeat Q4 Earnings, Retail Turns Extremely Bullish</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, a Bluebird bio logo is seen on a smartphone and a pc screen in the background. (Photo Illustration by Pavlo Gonchar/SOPA Images/LightRocket via Getty Images)

Bluebird Bio Stock Soars On Higher Upfront Payment Under Amended Merger Deal: Retail Gets More Bullish 

The upfront payment of $5 represents a 51% premium to Bluebird’s closing price of $3.31 on Tuesday.

Equity

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BRDG, AVTE, BLUE on Behalf of Shareholders

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BRDG, AVTE, BLUE on Behalf of Shareholders SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BRDG, AVTE, BLUE on Behalf of Shareholders...

BLUEBIRD BIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of bluebird bio, Inc. - BLUE

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (KSF) are investigating the proposed sale of bluebird bio, Inc. (NasdaqGS: BLUE) to Carlyle...

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of bluebird bio, Inc.

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of bluebird bio, Inc. ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of bluebird bio, Inc. PR Newswire NEW YORK, Feb. 21...

Once high-flying Bluebird Bio sells itself to private equity after tough times for the gene therapy maker

Bluebird Bio will sell itself to private equity firms Carlyle and SK Capital for about $30 million, the company said Friday...

$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of bluebird bio, Inc. - BLUE

$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of bluebird bio, Inc. - BLUE $HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of bluebird bio, Inc. - BLUE PR...

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BLUE, VOXX, CARA, CYTH on Behalf of Shareholders

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BLUE, VOXX, CARA, CYTH on Behalf of Shareholders SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BLUE, VOXX, CARA, CYTH on Behalf of...

Shareholder Alert: Ademi LLP investigates whether bluebird bio, Inc. is obtaining a Fair Price for its Public Shareholders

Ademi LLP is investigating bluebird (Nasdaq: BLUE) for possible breaches of fiduciary duty and other violations of law in its transaction with Carlyle and SK Capital. Click here to learn how to join...

BLUE Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of bluebird bio, Inc. Is Fair to Shareholders

Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of bluebird bio, Inc. (NASDAQ: BLUE) to Carlyle Group and SK Capital Partners, LP is fair to bluebird shareholders...

bluebird bio, Inc. is a clinical-stage biotechnology company, which engages in researching, developing and commercializing potentially transformative gene therapies for severe genetic diseases. It also offers ZYNTEGLO or beti-cel and SKYSONA or eli-cel gene therapies. The company was founded by Philippe Leboulch and Ronald C. Dorazio on April 16, 1992 and is headquartered in Somerville, MA.

Bluebird bio Inc

$AMZN

$MSFT

$GOOGL

$ORCL

Which cloud infrastructure stock offers the best long-term opportunity right now?

BLUE
Bluebird bio Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest BLUE News

BLUEBluebird bio Inc